Chang Alexandre Jin Bok Audi, Nahas Caio Sergio Rizkallah, Araujo Sergio E Alonso, Nahas Sergio C, Marques Carlos F Sparapan, Kiss Desiderio Roberto, Cecconello Ivan
Department of Gastroenterology, Surgical Division, University of São Paulo, School of Medicine, São Paulo, Brazil.
J Surg Educ. 2008 Jan-Feb;65(1):67-72. doi: 10.1016/j.jsurg.2007.11.002.
Sphincter preservation, disease control, and long-term survival are the main goals in the treatment of rectal cancer. Although transanal local excision is attractive because it is a sphincter sparing procedure, some contradictory data exist in the literature about its ability to locally control disease and provide overall survival comparable with radical procedures, even for patients with early stage tumor.
To compare transanal local excision and radical surgery treatment results based on the appropriate data in literature.
We reviewed the literature to identify the current recurrence and survival rates of both techniques as well as the salvage surgery success. A PubMed search of the last 10 years was performed, and a total of 10 nonrandomized studies were identified; only 1 study was prospective, 5 were comparative, and 5 were case reports.
Five-year overall survival rate varied from 69% to 83% in the local excision group versus 82% to 90% for the radical excision group. Local recurrence rates ranged from 9% to 20% for local excision and from 2% to 9% for radical surgery. Systemic recurrence rates ranged from 6% to 21% for local excision and from 2% to 9% for radical surgery.
Radical surgery is the more definitive cancer treatment; however, it does not eliminate local excision as a reasonable choice for many patients, who will have lesser procedure-related morbidity and will accept an increased risk of tumor recurrence, a prolonged period of postoperative cancer surveillance, and a decreased success rate by salvage surgery.
保留括约肌、控制疾病和长期生存是直肠癌治疗的主要目标。尽管经肛门局部切除因其是一种保留括约肌的手术而颇具吸引力,但文献中关于其局部控制疾病的能力以及提供与根治性手术相当的总体生存率的数据存在一些矛盾,即使对于早期肿瘤患者也是如此。
根据文献中的适当数据比较经肛门局部切除和根治性手术的治疗结果。
我们回顾文献以确定这两种技术当前的复发率、生存率以及挽救性手术的成功率。对过去10年进行了PubMed检索,共确定了10项非随机研究;只有1项研究是前瞻性的,5项是比较性的,5项是病例报告。
局部切除组的5年总生存率在69%至83%之间,而根治性切除组为82%至90%。局部切除的局部复发率在9%至20%之间,根治性手术的局部复发率在2%至9%之间。局部切除的全身复发率在6%至21%之间,根治性手术的全身复发率在2%至9%之间。
根治性手术是更具确定性的癌症治疗方法;然而,对于许多患者来说,它并没有排除局部切除作为一种合理选择,这些患者手术相关的发病率较低,并且愿意接受肿瘤复发风险增加、术后癌症监测期延长以及挽救性手术成功率降低的情况。